• TKVA share price: temporarily unavailable. We are sorry, but this information is temporarily unavailable.

  • TKVA stock price change: temporarily unavailable. We are sorry, but this information is temporarily unavailable.

  • TKVA market open/close: temporarily unavailable. We are sorry, but this information is temporarily unavailable.

Key terms

About TKVA

Salspera, Inc is a clinical-stage biotechnology company committed to developing novel therapies for solid tumor cancer. The company was founded on June 26, 2017 by Eddie Moradian and Daniel Saltzman and is headquartered in Cambridge, MA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

  • TKVA market cap: currently unavailable. Sorry, we currently don't have enough data to create an insight.

Key terms

Smart score

Latest TKVA news

No recent TipRanks articles are available for TKVA

No recent press releases are available for TKVA

TKVA Financials

1-year income & revenue

  • TKVA total_revenue: currently unavailable. Sorry, we currently don't have enough data to create an insight.

  • TKVA net income: currently unavailable. Sorry, we currently don't have enough data to create an insight.

  • TKVA earnings per share: currently unavailable. Sorry, we currently don't have enough data to create an insight.

Key terms

TKVA Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

TKVA Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range
  • How competitors are chosen

    TKVA's competitors are included in the Health Technology sector and Biotechnology group

  • TKVA market cap: currently unavailable. Sorry, we currently don't have enough data to create an insight.

Key terms

Latest investing news